The Infirmation : As AWS Use Soars, Companies Surprised by Cloud Bills

As AWS Use Soars, Companies Surprised by Cloud Bills

interest executives got a surprise during last year’s holiday season. Consumers were spending so much time using the online scrapbook that Pinterest’s computing bills on Amazon Web Services—the internet retailer’s cloud offering—had shot past their expectations.

Pinterest, which had paid in advance for AWS’s services, had to buy additional capacity at a higher price. That contributed to Pinterest spending roughly $190 million on AWS last year, $20 million more than it had initially expected, according to a person close to the company and figures seen by The Information.

Pinterest is hardly alone in ending up with a bigger than expected AWS bill, according to an examination of the AWS spending patterns of five large companies conducted by The Information.


>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:

  • TEX +10.5%, VEON +6.2%, MOGU +6%, CRI +5.5%, SSL +3.3%, PLAN +2.7%

M&A news:

  • ONCE +120% (to be acquired by Roche for $114.50 per share)
  • CMTA +75.6% (to be acquired by Ipsen (IPSEY) for $25.00 per share in cash upfront plus a CVR of $6.00 per share)
  • GE +17% (to sell its BioPharma business to Danaher (DHR) for total consideration of $21.4 bln),  DHR +6.4%

Select China related names showing strength:

  • XNET +9.2%, BZUN +8.4%, MOMO +6.8%, WB +5.2%, CMCM +4.9%, JMEI +4.9%, JD +4.4%, VIPS +4.4%, YY +4.1%, WUBA +3.7%, EDU +3%, SOHU +2.9%, BABA +2.6%, BITA +2.5%, BIDU +2.4%, CAT +1.3%

Select Biotech stocks trading higher:

  • QURE +17.3%, BOLD +15.4%, RGNX +10.8%, CRSP +10.5%, SGMO +9.9%, VYGR +6.9%, EDIT +6%, NTLA +4.9%, OPHT +4.3%, SRPT +4.3%, BMRN +4.1%

Select semiconductor related names showing strength following ONCE acquisition:

  • STM +3.5%, MU +2.4%, AMD +2.3%, WDC +2.3%, XLNX +2%, NVDA +1.8%, QCOM +1.7%, ASML +1.5%

Other news:

  • FENG +40.3% (announces letter of intent to sell 32% of the total outstanding shares of Particle Inc)
  • INSY +8.4% (presented poster of initial pharmacokinetic study of epinephrine nasal spray for the emergency treatment of allergic reactions)
  • BCRX +7.9% (reports ZENITH-1 results)
  • FOLD +7.7% (granted FDA Breakthrough Therapy Designation for AT-GAA for the treatment of late onset Pompe disease)'
  • AVP +6.5% (continued strength)
  • STKL +3% (to sell its specialty and organic soy and corn business to Pipeline Foods for $66.5 mln)
  • CSIQ +2% (continued strength)
  • BHC +1.5% (FDA approval of LOTEMAX SM)
  • NFLX +1.2% (Netflix won multiple Oscars last night)

Analyst comments:

  • PLSE +4.1% (initiated with a Buy at H.C. Wainwright)
  • INFN +3.6% (upgraded to Neutral from Sell at MKM Partners)
  • NCLH +2% (upgraded to Outperform from Neutral at Macquarie)
  • CBOE +1.5% (upgraded to Overweight from Neutral at JP Morgan)